COVID-19 News: Bharat Biotech, Serum Institute Vaccines Get Approval

Two vaccines for coronavirus, Oxford Institute's Covishield, which is being developed by the Pune-based Serum Institute, and Bharat Biotech's Covaxin, received emergency approval from the country's drug regulator today. The Drug Controller General of India VG Somani said both firms submitted data on their trial runs and both have been granted permission for "restricted use". Covishield was found to be 70.42 per cent effective and Bharat Biotech's Covaxin was "safe and provides a robust immune response", he said.

NDTV is one of the leaders in the production and broadcasting of un-biased and comprehensive news and entertainment programmes in India and abroad. NDTV delivers reliable information across all platforms: TV, Internet and Mobile.

Subscribe for more videos: https://www.youtube.com/user/ndtv?sub_confirmation=1
Like us on Facebook: https://www.facebook.com/ndtv
Follow us on Twitter: https://twitter.com/ndtv
Download the NDTV Apps: http://www.ndtv.com/page/apps
Watch more videos: http://www.ndtv.com/video?yt